ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

AACR Using Its Clout To Urge Higher NCI Budget

May 24, 1991

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008